Cargando…
Circulating microRNAs as potential new biomarkers for prostate cancer
Since they were first described in the 1990s, circulating microRNAs (miRNAs) have provided an active and rapidly evolving area of current research that has the potential to transform cancer diagnostics and therapeutics. In particular, miRNAs could provide potential new biomarkers for prostate cancer...
Autores principales: | Sita-Lumsden, A, Dart, D A, Waxman, J, Bevan, C L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670496/ https://www.ncbi.nlm.nih.gov/pubmed/23632485 http://dx.doi.org/10.1038/bjc.2013.192 |
Ejemplares similares
-
Circulating microRNAs as biomarkers for diabetic neuropathy: A novel approach
por: Xourgia, Eleni, et al.
Publicado: (2018) -
Role of circulating microRNAs in liver diseases
por: Loosen, Sven H, et al.
Publicado: (2017) -
MicroRNAs sound off
por: Weston, Michael D, et al.
Publicado: (2009) -
MicroRNAs: new players in acute myeloid leukaemia
por: Havelange, V, et al.
Publicado: (2009) -
Are microRNAs suitable biomarkers of immunity to tuberculosis?
por: Ueberberg, Bianca, et al.
Publicado: (2014)